JP Morgan Chase’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,441,724
Closed -$205M 7388
2022
Q3
$205M Buy
7,441,724
+7,175,130
+2,691% +$178M 0.03% 483
2022
Q2
$6.15M Sell
266,594
-319,792
-55% -$7.47M ﹤0.01% 2600
2022
Q1
$12.8M Sell
586,386
-909,282
-61% -$18.9M ﹤0.01% 2136
2021
Q4
$32M Sell
1,495,668
-5,252,432
-78% -$110M ﹤0.01% 1460
2021
Q3
$141M Sell
6,748,100
-3,223,563
-32% -$70.3M 0.02% 706
2021
Q2
$230M Sell
9,971,663
-275,877
-3% -$6.35M 0.03% 557
2021
Q1
$226M Buy
10,247,540
+9,975,953
+3,673% +$231M 0.03% 534
2020
Q4
$5.07M Buy
271,587
+247,549
+1,030% +$4.07M ﹤0.01% 2805
2020
Q3
$344K Sell
24,038
-125,921
-84% -$1.6M ﹤0.01% 4142
2020
Q2
$1.68M Sell
149,959
-28,625
-16% -$321K ﹤0.01% 3217
2020
Q1
$1.78M Buy
178,584
+143,649
+411% +$2.01M ﹤0.01% 3055
2019
Q4
$573K Buy
34,935
+27,124
+347% +$364K ﹤0.01% 4166
2019
Q3
$94K Sell
7,811
-2,357,689
-100% -$32.4M ﹤0.01% 4927
2019
Q2
$35.5M Buy
+2,365,500
New +$35M 0.01% 1178

Other funds holding CHNG

JP Morgan Chase's CHNG Position: Q4 2022 in Review

JP Morgan Chase sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 7,441,724 shares — an estimated $205M sold.

JP Morgan Chase first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $230M in Q2 2021. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • JP Morgan Chase reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 7,441,724 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $205M.
  • JP Morgan Chase first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • JP Morgan Chase's Change Healthcare Inc. Common Stock position peaked at $230M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.